Pharmaceutical Companies
PRA Announces Strategic Relationship with Amgen
Published in Pharma Business Week, May 7th, 2012
2012 MAY 7 -- PRA, a leading Clinical Research Organization, announces a new agreement with Amgen for a series of Phase III studies to develop several biosimilar drugs on a worldwide basis. It is intended that PRA will serve as the sole provider of CRO services for these studies. A global leader in the biotechnology space, Amgen conducted a thorough search process to identify a CRO for Amgen's biosimilar development program and selected PRA. Amgen and PRA signed the agreement in April 2012.
Under the new agreement, Amgen and PRA will work together to execute Phase III studies related to Amgen's current biosimilar portfolio. The agreement is intended to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
Source: Pharma Business Week (2012-05-07)
More Articles from Pharma Business Week
- Research and Markets
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2012 - Zimbabwe's Economy to Grow By 7.4% In 2012 - Pharmacokinetics
Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate - Epilepsy
Upsher-Smith Expands Epilog.us With Addition Of Expert Opinion On Epilepsy & Comorbidities - Pharmaceutical Companies
Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders - Epilepsy
Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters - Diabetes
Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes Investigational Therapies Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone - More from this issue of Pharma Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
